Interaction between diets, polymorphisms and plasma lipid levels

Clinical Lipidology

Volumn 5, Issue 3, 2010, Pages 421-438

  Rudkowska, Iwona ^a   Vohl, Marie Claude ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

diet; genetic variation; HDL C; LDL C; low fat diet; monounsaturated fat; n 3 polyunsaturated fat; polyunsaturated fat; total cholesterol; triglyceride

Indexed keywords

MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID;

CARDIOVASCULAR DISEASE; DIET THERAPY; FAT INTAKE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

EID: 77953818338     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.26     Document Type: Review

References (73)

1. Grundy SM, Cleeman JI, Merz CN et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J. Am. Coll. Cardiol. 44(3), 720-732 (2004).
2. Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81(4A), B7-B12 (1998).
3. Lecerf JM: Fatty acids and cardiovascular disease. Nutr. Rev. 67(5), 273-283 (2009).
4. Allen EV, Katz LN, Keys A, Gofman JW: Atherosclerosis; a symposium. Circulation 5(1), 98-134 (1952).
5. Schaefer EJ, Lamon-Fava S, Ausman LM et al.: Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am. J. Clin. Nutr. 65(3), 823-830 (1997).
6. de Lorgeril M: Mediterranean diet in the prevention of coronary heart disease. Nutrition 14(1), 55-57 (1998).
7. Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Ordovas JM: Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler. Suppl. 9(2), 49-55 (2008).
8. Corella D, Ordovas JM: Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr. 25, 341-390 (2005).
9. Masson LF, McNeill G, Avenell A: Genetic variation and the lipid response to dietary intervention: a systematic review. Am. J. Clin. Nutr. 77(5), 1098-1111 (2003).
10. Couture P, Archer WR, Lamarche B et al.: Influences of apolipoprotein E polymorphism on the response of plasma lipids to the ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet. Metabolism 52(11), 1454-1459 (2003).
11. Zambon D, Ros E, Casals E, Sanllehy C, Bertomeu A, Campero I: Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. Am. J. Clin. Nutr. 61(1), 141-148 (1995).
12. Moreno JA, Perez-Jimenez F, Moreno-Luna R et al.: The effect of ApoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. Br. J. Nutr. 101(12), 1745-1752 (2009).
13. Moreno JA, Perez-Jimenez F, Marin C et al.: The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J. Nutr. 134(10), 2517-2522 (2004).
14. Lopez-Miranda J, Ordovas JM, Espino A et al.: Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343(8908), 1246-1249 (1994).
15. Russo GT, Meigs JB, Cupples LA et al.: Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158(1), 173-181 (2001).
16. Lopez-Miranda J, Ordovas JM, Marin C: The SstI polymorphic site at the apolipoprotein C-III gene predicts plasma low-density lipoprotein response to changes in dietary fat in young men. Circulation 90, I (1994).
17. Perez-Martinez P, Gomez P, Paz E et al.: Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet. Nutr. Metab. Cardiovasc. Dis. 11(4), 237-243 (2001).
18. Jansen S, Lopez-Miranda J, Ordovas JM et al.: Effect of 360His mutation in apolipoprotein A-IV on plasma HDL-cholesterol response to dietary fat. J. Lipid Res. 38(10), 1995-2002 (1997). (Pubitemid 27468008)
19. Jansen S, Lopez-Miranda J, Salas J et al.: Effect of 347-serine mutation in apoprotein A-IV on plasma LDL cholesterol response to dietary fat. Arterioscler. Thromb. Vasc. Biol. 17(8), 1532-1538 (1997). (Pubitemid 27387774)
20. Lopez-Miranda J, Ordovas JM, Ostos MA et al.: Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler. Thromb. Vasc. Biol. 17(9), 1765-1773 (1997).
21. Lopez-Miranda J, Marin C, Castro P et al.: The effect of apolipoprotein B xbaI polymorphism on plasma lipid response to dietary fat. Eur. J. Clin. Invest. 30(8), 678-684 (2000).
22. Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E: Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin. Genet. 47(1), 1-12 (1995).
23. Perez-Martinez P, Perez-Jimenez F, Ordovas JM et al.: The APOB -516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population. Nutr. Metab. Cardiovasc. Dis. 17(3), 224-229 (2007).
24. Ordovas JM, Corella D, Demissie S et al.: Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106(18), 2315-2321 (2002).
25. Tai ES, Corella D, Deurenberg-Yap M et al.: Dietary fat interacts with the -514C>T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J. Nutr. 133(11), 3399-3408 (2003).
26. Lindi V, Schwab U, Louheranta A et al.: The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: the KANWU Study. Nutr. Metab. Cardiovasc. Dis. 18(2), 88-95 (2008).
27. Memisoglu A, Hu FB, Hankinson SE et al.: Interaction between a peroxisome proliferator-activated receptor g gene polymorphism and dietary fat intake in relation to body mass. Hum. Mol. Genet. 12(22), 2923-2929 (2003).
28. Vincent S, Planells R, Defoort C et al.: Genetic polymorphisms and lipoprotein responses to diets. Proc. Nutr. Soc. 61(4), 427-434 (2002).
29. Lairon D, Defoort C, Martin JC, Amiot-Carlin MJ, Gastaldi M, Planells R: Nutrigenetics: links between genetic background and response to Mediterranean-type diets. Public Health Nutr. 12(9A), 1601-1606 (2009).
30. Hu FB, Manson JE, Willett WC: Types of dietary fat and risk of coronary heart disease: a critical review. J. Am. Coll. Nutr. 20(1), 5-19 (2001).
31. Hu FB, Stampfer MJ, Manson JE et al.: Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am. J. Clin. Nutr. 70(6), 1001-1008 (1999).
32. Mata P, Lopez-Miranda J, Pocovi M et al.: Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 137(2), 367-376 (1998).
33. Ordovas JM, Corella D, Cupples LA et al.: Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am. J. Clin. Nutr. 75(1), 38-46 (2002).
34. Weinberg RB, Geissinger BW, Kasala K et al.: Effect of apolipoprotein A-IV genotype and dietary fat on cholesterol absorption in humans. J. Lipid Res. 41(12), 2035-2041 (2000).
35. Wallace AJ, Humphries SE, Fisher RM, Mann JI, Chisholm A, Sutherland WH: Genetic factors associated with response of LDL subfractions to change in the nature of dietary fat. Atherosclerosis 149(2), 387-394 (2000).
36. Lai CQ, Corella D, Demissie S et al.: Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 113(17), 2062-2070 (2006).
37. Paula RS, Souza VC, Benedet AL et al.: Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women. Mol. Cell. Biochem. 337(1-2), 307-315 (2009).
38. Zhong S, Sharp DS, Grove JS et al.: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97(12), 2917-2923 (1996).
39. Darabi M, Abolfathi AA, Noori M et al.: Cholesteryl ester transfer protein I405V polymorphism influences apolipoprotein A-I response to a change in dietary fatty acid composition. Horm. Metab. Res. 41(7), 554-558 (2009).
40. Wallace AJ, Mann JI, Sutherland WH et al.: Variants in the cholesterol ester transfer protein and lipoprotein lipase genes are predictors of plasma cholesterol response to dietary change. Atherosclerosis 152(2), 327-336 (2000).
41. Humphries SE, Talmud PJ, Cox C, Sutherland W, Mann J: Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge. QJM 89(9), 671-680 (1996).
42. Paradis ME, Couture P, Bosse Y et al.: The T111I mutation in the EL gene modulates the impact of dietary fat on the HDL profile in women. J. Lipid Res. 44(10), 1902-1908 (2003).
43. Sapone A, Peters JM, Sakai S et al.: The human peroxisome proliferator-activated receptor a gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics 10(4), 321-333 (2000).
44. Rudkowska I, Verreault M, Barbier O, Vohl MC: Differences in transcriptional activation by the two allelic (L162V polymorphic) variants of PPARa after omega-3 fatty acids treatment. PPAR Res. DOI:10.1155/2009/369602 (2009) (Epub ahead of print).
45. Robitaille J, Brouillette C, Houde A et al.: Association between the PPARa-L162V polymorphism and components of the metabolic syndrome. J. Hum. Genet. 49(9), 482-489 (2004).
46. Tai ES, Corella D, Demissie S et al.: Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J. Nutr. 135(3), 397-403 (2005).
47. Paradis AM, Fontaine-Bisson B, Bosse Y et al.: The peroxisome proliferator-activated receptor a Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. Am. J. Clin. Nutr. 81(2), 523-530 (2005).
48. Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E: Peroxisome proliferator-activated receptor a genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 87(6), 1926-1931 (2008).
49. de Lorgeril M, Salen P: Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease. J. Cardiovasc. Med. 8(Suppl. 1), S38-S41 (2007).
50. Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65(5 Suppl.), S1645-S1654 (1997).
51. Minihane AM, Khan S, Leigh-Firbank EC et al.: ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler. Thromb. Vasc. Biol. 20(8), 1990-1997 (2000).
52. Caron-Dorval D, Paquet P, Paradis AM et al.: Effect of the PPAR-A L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids. J. Nutrigenet. Nutrigenomics 1, 205-212 (2008).
53. Lindi V, Schwab U, Louheranta A et al.: Impact of the Pro12Ala polymorphism of the PPAR-g2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol. Genet. Metab 79(1), 52-60 (2003).
54. Kris-Etherton P, Eckel RH, Howard BV, St Jeor S, Bazzarre TL: AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 103(13), 1823-1825 (2001).
55. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269(23), 3015-3023 (1993).
56. Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R, Paavilainen E: Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet 2(7782), 835-838 (1972).
57. Moreno JA, Perez-Jimenez F, Marin C et al.: Apolipoprotein E gene promoter -219GT polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat. Am. J. Clin. Nutr. 80(5), 1404-1409 (2004).
58. Carmena-Ramon RF, Ordovas JM, Ascaso JF, Real J, Priego MA, Carmena R: Influence of genetic variation at the Apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia. Atherosclerosis 139(1), 107-113 (1998). (Pubitemid 28341872)
59. Carmena-Ramon R, Ascaso JF, Real JT, Ordovas JM, Carmena R: Genetic variation at the ApoA-IV gene locus and response to diet in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 18(8), 1266-1274 (1998).
60. Ilmonen M, Helio T, Butler R et al.: Two new immunogenetic polymorphisms of the ApoB gene and their effect on serum lipid levels and responses to changes in dietary fat intake. Arterioscler. Thromb. Vasc. Biol. 15(9), 1287-1293 (1995).
61. Hammoud A, Gastaldi M, Maillot M et al.: APOB-516 T allele homozygous subjects are unresponsive to dietary changes in a three-month primary intervention study targeted to reduce fat intake. Genes Nutr. 5(1), 29-37 (2009).
62. Talmud PJ, Boerwinkle E, Xu CF et al.: Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet. Epidemiol. 9(4), 249-260 (1992).
63. Riestra P, Lopez-Simon L, Ortega H et al.: Fat intake influences the effect of the hepatic lipase C-514T polymorphism on HDL-cholesterol levels in children. Exp. Biol. Med. 234(7), 744-749 (2009).
64. Barcelos AL, Chies R, Almeida SE et al.: Association of CYP7A1 -278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients. Braz. J. Med. Biol. Res. 42(6), 487-493 (2009).
65. Perez-Martinez P, Ordovas JM, Lopez-Miranda J et al.: Polymorphism exon 1 variant at the locus of the scavenger receptor class B type I gene: influence on plasma LDL cholesterol in healthy subjects during the consumption of diets with different fat contents. Am. J. Clin. Nutr. 77(4), 809-813 (2003).
66. Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R: Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin. Chem. Lab. Med. 45(3), 316-320 (2007).
67. Mattei J, Demissie S, Tucker KL, Ordovas JM: Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J. Nutr. 139(12), 2301-2308, (2009).
68. Rantala M, Rantala TT, Savolainen MJ, Friedlander Y, Kesaniemi YA: Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am. J. Clin. Nutr. 71(3), 713-724 (2000).
69. Robitaille J, Brouillette C, Lemieux S, Perusse L, Gaudet D, Vohl MC: Plasma concentrations of apolipoprotein B are modulated by a gene-diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol. Genet. Metab. 82(4), 296-303 (2004).
70. Robitaille J, Gaudet D, Perusse L, Vohl MC: Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-d -87T>C polymorphism and dietary fat in French-Canadians. Int. J. Obes. 31(3), 411-417 (2007).
71. Robitaille J, Houde A, Lemieux S, Gaudet D, Perusse L, Vohl MC: The lipoprotein/lipid profile is modulated by a gene-diet interaction effect between polymorphisms in the liver X receptor-a and dietary cholesterol intake in French-Canadians. Br. J. Nutr. 97(1), 11-18 (2007).
72. Robitaille J, Perusse L, Bouchard C, Vohl MC: Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study. Obesity 15(9), 2336-2347 (2007). (Pubitemid 350004102)
73. Chamberlain AM, Schreiner PJ, Fornage M, Loria CM, Siscovick D, Boerwinkle E: Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Metabolism 58(9), 1222-1228 (2009).